Prof. Dr. Reza Nejadnik

Prof. Dr. Reza Nejadnik brings experience and expertise from academic and industrial work in the field of drug product development for biopharmaceuticals. Reza is currently a faculty member of the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa.

His research is focused on protein pharmaceuticals, their formulation and characterization, and the interaction of biologics with interfaces. His topics of interest include the delivery, handling and manufacturing processes of protein therapeutics. Reza received his PhD from the University of Groningen in the Netherlands in 2009. Following a few years of research in the area of proteins, nano and biomaterials at The University of Texas, Northwestern University and Radboud University Nijmegen, Reza joined the Leiden Academic Center for Drug Research to co-lead a European public-private partnership project (COMPACT) that addressed the current challenges with formulation and delivery of macromolecules. In the four years of the COMPACT project, Reza’s research focused on the characterization and understanding of protein aggregation in complex formulations as well as protein-material interactions. Reza then joined Sanofi’s Global Biologic Drug Product Development team and headed a formulation and process development laboratory in the Company’s R&D hub in Frankfurt, Germany. He developed early formulations and drug product manufacturing processes for several molecules in various modalities, including antibodies and nanobodies.